{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:00:58Z","timestamp":1790402458615,"version":"4.1.0"},"reference-count":43,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2008,5,2]],"date-time":"2008-05-02T00:00:00Z","timestamp":1209686400000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Clinical Hypertension"],"published-print":{"date-parts":[[2008,5]]},"abstract":"<jats:p> <jats:italic>Blacks have the highest rates of hypertension and cardiovascular disease, with earlier onset, greater severity, and more target organ damage including coronary disease, heart failure, stroke, and end\u2010stage renal disease. A major reason is the greater prevalence of other cardiovascular disease risk factors, particularly obesity, inactivity, and diabetes mellitus, along with socioeconomic differences, adherence, and achievement of goals. This review focuses on the burden of cardiovascular disease in blacks. Therapeutic lifestyle changes and pharmacologic interventions to decrease clinical events in this high\u2010risk group are described. Intensive blood pressure control is a primary means of \u201cstopping the clock\u201d in the progression of cardiovascular disease and renal disease. Thiazide diuretics remain primary first\u2010step agents, especially for uncomplicated hypertension; calcium channel blockers are also efficacious. However, renin\u2010angiotensin system modulators may also be beneficial, especially with a diuretic, considering the high prevalence in this group of patients of compelling indications for use of such agents.<\/jats:italic> <\/jats:p>","DOI":"10.1111\/j.1751-7176.2008.07918.x","type":"journal-article","created":{"date-parts":[[2008,5,5]],"date-time":"2008-05-05T04:06:30Z","timestamp":1209960390000},"page":"382-389","source":"Crossref","is-referenced-by-count":15,"title":["Cardiovascular Disease in Blacks: Can We Stop the Clock?"],"prefix":"10.1111","volume":"10","author":[{"given":"Keith C.","family":"Ferdinand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,5,2]]},"reference":[{"key":"e_1_2_9_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000142248.54761.56"},{"key":"e_1_2_9_3_2","volume-title":"Heart Disease and Stroke Statistics: 2007 Update","author":"American Heart Association","year":"2007"},{"key":"e_1_2_9_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000252676.46043.18"},{"key":"e_1_2_9_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.5.525"},{"key":"e_1_2_9_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-6175.2006.05295.x"},{"key":"e_1_2_9_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjhyper.2003.07.007"},{"key":"e_1_2_9_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000157743.54710.04"},{"key":"e_1_2_9_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-005-0020-5"},{"key":"e_1_2_9_10_2","doi-asserted-by":"publisher","DOI":"10.1054\/S1071-9164(03)00588-8"},{"key":"e_1_2_9_11_2","doi-asserted-by":"publisher","DOI":"10.1006\/pmed.2000.0807"},{"key":"e_1_2_9_12_2","first-page":"785","article-title":"Centers for Disease Control and Prevention. Physical activity levels among children aged 9\u201313 years: United States, 2002","volume":"52","year":"2003","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_9_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000026493.18542.6A"},{"key":"e_1_2_9_14_2","volume-title":"USRDS 2006 Annual Data Report: Atlas of End\u2010Stage Renal Disease in the United States","year":"2006"},{"key":"e_1_2_9_15_2","volume-title":"The Diabetes Epidemic Among African Americans Fact Sheet","year":"2005"},{"key":"e_1_2_9_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2006.01.079"},{"key":"e_1_2_9_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-6175.2006.05112.x"},{"key":"e_1_2_9_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2005.08.019"},{"key":"e_1_2_9_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000107251.49515.c2"},{"key":"e_1_2_9_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11911-8"},{"key":"e_1_2_9_21_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.159.3.285"},{"key":"e_1_2_9_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39147.604896.55"},{"key":"e_1_2_9_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.30.7.1333"},{"key":"e_1_2_9_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.18.2217"},{"key":"e_1_2_9_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1982.165"},{"key":"e_1_2_9_26_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.23.2981"},{"key":"e_1_2_9_27_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.13.1595"},{"key":"e_1_2_9_28_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa060838"},{"key":"e_1_2_9_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(01)01296-1"},{"key":"e_1_2_9_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(01)80101-6"},{"key":"e_1_2_9_31_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000180457.82483.6b"},{"key":"e_1_2_9_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14282-1"},{"key":"e_1_2_9_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16451-9"},{"key":"e_1_2_9_34_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa065061"},{"key":"e_1_2_9_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60108-1"},{"key":"e_1_2_9_36_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.21.2719"},{"key":"e_1_2_9_37_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2006.08.004"},{"key":"e_1_2_9_38_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011161"},{"key":"e_1_2_9_39_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e328277596e"},{"key":"e_1_2_9_40_2","first-page":"A186","article-title":"Dose\u2010related antihypertensive effects of valsartan therapy in African American patients with type 2 diabetes: the Diovan Reduction of Proteinuria (DROP) study","volume":"9","author":"Weir MR","year":"2007","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"e_1_2_9_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08089-3"},{"key":"e_1_2_9_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2003.11.029"},{"key":"e_1_2_9_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2004.03.020"},{"key":"e_1_2_9_44_2","first-page":"239","article-title":"Cardiologists should care about glucose: most people with CV disease or risk factors have diabetes or significant glycaemic abnormalities","volume":"25","author":"McMurray JJ","year":"2004","journal-title":"Eur Heart J"}],"container-title":["The Journal of Clinical Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1751-7176.2008.07918.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1751-7176.2008.07918.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T15:41:01Z","timestamp":1697038861000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1751-7176.2008.07918.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["10.1111\/j.1751-7176.2008.07918.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1751-7176.2008.07918.x","archive":["Portico"],"relation":{},"ISSN":["1524-6175","1751-7176"],"issn-type":[{"value":"1524-6175","type":"print"},{"value":"1751-7176","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}